The Group represents specialty medicines biopharma companies in key emerging markets through licensing and partnership agreements, with FarmaMondo taking care of regulatory approvals, pricing, reimbursement and medical affairs as well as marketing and sales.
Alongside our named patient services, the FarmaMondo Group’s licensed medicines distribution capabilities allow optimal life cycle management in several of the most promising emerging markets.
A phased approach in which a therapy is initially supplied on a named patients basis and later gains marketing authorization optimizes drug potential and market access investments. The FarmaMondo Group offers regional partnerships for commercialization of specialty medicines in Switzerland as well as the Russia and CIS, Baltic and Middle East regions and certain countries in Latin America. Pharmaceutical and biotech companies wishing to join our growing global partnerships portfolio should contact us at firstname.lastname@example.org.